高级搜索
多形性腺瘤内癌病理形态及免疫组化研究[J]. 肿瘤防治研究, 2001, 28(06): 444-447. DOI: 10.3971/j.issn.1000-8578.487
引用本文: 多形性腺瘤内癌病理形态及免疫组化研究[J]. 肿瘤防治研究, 2001, 28(06): 444-447. DOI: 10.3971/j.issn.1000-8578.487
The Pathologic Picture and Immunohistochemical Study Of Carcinoma In Pleomorphic Adenoma[J]. Cancer Research on Prevention and Treatment, 2001, 28(06): 444-447. DOI: 10.3971/j.issn.1000-8578.487
Citation: The Pathologic Picture and Immunohistochemical Study Of Carcinoma In Pleomorphic Adenoma[J]. Cancer Research on Prevention and Treatment, 2001, 28(06): 444-447. DOI: 10.3971/j.issn.1000-8578.487

多形性腺瘤内癌病理形态及免疫组化研究

The Pathologic Picture and Immunohistochemical Study Of Carcinoma In Pleomorphic Adenoma

  • 摘要: 目的 通过多形性腺瘤内癌病理形态及免疫组化研究 1、探讨多形性腺瘤伴细胞生长活跃, 原位癌及其亚型之间的差异。 2、对多形性腺瘤内癌病理形态、细胞增殖活性及癌基因方面的联合指标进行测定, 加深对生物学行为的认识。方法 选用多形性腺瘤伴细胞生长活跃 36例、恶性混合瘤 9例、侵袭性癌 2 6例、良性多形性腺瘤 18例重新连续节片, 作特染AgNORs, 免疫组化PCNA、Ki 6 7、p5 3、VEGF并复习临床资料。 结果 多形性腺瘤内癌及其亚型, AgNORs及Ki6 7、PCNA、VEGF、p5 3表达阳性, 而癌旁组织表达为可疑阳性或阴性。 结论 根据多形性腺瘤内癌病理形态, 细胞增殖活性、VEGF、p5 3的检测, 首次在国内提出了原位癌、侵袭性癌及恶性混合瘤病理学诊断标准及其鉴别诊断。

     

    Abstract: Objective 1. To solve mixed tumor with cell activated growth, so called"semi-malignant".malignant and the difference with subtype.2.measure the pathologic picture of pleomorphic adenoma and its combinated index with cell proliferation activity and oncogene, deepen the knowledge of biological behavior. Methods select 36 cases of mixed tumor with cell growth active and 9 cases of malignant mixed tumor and 16 cases of invasive carinoma, to slice up continuously, and stain with specific and immuohistochemistry,...

     

/

返回文章
返回